ABL Bio Inc. (298380.KQ)

KRW 27400.0

(-5.03%)

Eps Summary of ABL Bio Inc.

ABL Bio Inc.'s latest annual eps in 2023 was -55.32 KRW , down -182.0% from previous year.
ABL Bio Inc.'s latest quarterly eps in 2024 Q1 was -249.96 KRW , up 4.33% from previous quarter.
ABL Bio Inc. reported an annual eps of 67.46 KRW in 2022, up 107.27% from previous year.
ABL Bio Inc. reported an annual eps of -927.36 KRW in 2021, up 23.18% from previous year.
ABL Bio Inc. reported a quarterly eps of -237.93 KRW for 2024 Q2, up 4.81% from previous quarter.
ABL Bio Inc. reported a quarterly eps of N/A for 2023 FY, down -182.0% from previous quarter.

Annual Eps Chart of ABL Bio Inc. (2023 - 2016)

Historical Annual Eps of ABL Bio Inc. (2023 - 2016)

Year	Eps	Eps Growth
2023	-55.32 KRW	-182.0%
2022	67.46 KRW	107.27%
2021	-927.36 KRW	23.18%
2020	-1207.19 KRW	-47.53%
2019	-818.27 KRW	78.49%
2018	-3804.17 KRW	-126.96%
2017	-1676.15 KRW	-446.12%
2016	-306.92 KRW	0.0%

Year	Eps	Eps Growth
2024 Q1	-249.96 KRW	4.33%
2024 Q2	-237.93 KRW	4.81%
2023 FY	- KRW	-182.0%
2023 Q4	-261.28 KRW	-204.34%
2023 Q3	-85.85 KRW	60.36%
2023 Q2	-216.57 KRW	-142.53%
2023 Q1	509.21 KRW	236.58%
2022 Q1	-181.33 KRW	48.75%
2022 FY	- KRW	107.27%
2022 Q4	-372.84 KRW	-164.73%
2022 Q3	575.96 KRW	1185.34%
2022 Q2	44.81 KRW	124.71%
2021 Q3	-211.34 KRW	-23.89%
2021 Q2	-170.58 KRW	10.74%
2021 Q4	-353.84 KRW	-67.43%
2021 Q1	-191.11 KRW	0.0%
2021 FY	- KRW	23.18%
2020 FY	- KRW	-47.53%
2019 FY	- KRW	78.49%
2018 FY	- KRW	-126.96%
2017 FY	- KRW	-446.12%
2016 FY	- KRW	0.0%

Peer Eps Comparison of ABL Bio Inc.

Name	Eps	Eps Difference
Sam Chun Dang Pharm. Co., Ltd	-463.03 KRW	88.053%
Hyundai Bioscience Co., Ltd.	-365.00 KRW	84.844%
ST Pharm Co.,Ltd.	1041.07 KRW	105.314%
Cellid, Co., Ltd.	-1078.05 KRW	94.869%